Recordati Rare Diseases Inc. today announced the presentation of real-world data that build upon the safety data of sutimlimab, an FDA-approved therapy for hemolysis in adults with cold agglutinin ...
The U.S. Army is advancing its personnel readiness capabilities with data-driven tools that provide leaders with real-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback